用于脊髓灰质炎1型脊髓灰质炎病毒的MAPREC测定的低突变病毒参考(沙宾
                    | 【编号】:NIBSC00/416 【名称】:用于脊髓灰质炎1型脊髓灰质炎病毒的MAPREC测定的低突变病毒参考(沙宾 【规格】:个 【价格】:2600元  用于脊髓灰质炎1型脊髓灰质炎病毒的MAPREC测定的低突变病毒参考(沙宾)(第一国际参考制剂)
	  编号:NIBSC00/416  
	  英文:Low Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation) 
	  标准类型:国际参考制剂 
	  规格:1个  
	Customer Notes 00/410 - MAPREC assay of poliovirus type 1 (Sabin).100% 480-A, 525-C DNA(1st International Reference Preparation) 00/418 - MAPREC assay of poliovirus type 1 (Sabin) (1st International Standard) 00/422 - MAPREC assay of poliovirus type 1 (Sabin)High Mutant Virus Reference(1st International Reference Preparation) 
	  描述:1. INTENDED USE 
	This Low Mutant Virus Reference (LMVR) is intended to be used as a 
	control to determine whether an individual determination is valid in the 
	MAPREC assay. The % 480-A and 525-C content of the candidate 
	reference materials were chosen such that the biological variation 
	inherent in the MAPREC method would lead to an invalid result in only 
	about 1 in 100 determinations. 
	2. CAUTION 
	This preparation is not for administration to humans or animals in 
	the human food chain. 
	The material is of bovine origin. The material is certified to be obtained 
	from animals taken from a closed herd in the female line since 1980, in 
	which no animal has been clinically suspected of having BSE & which 
	has not been fed rations containing ruminant derived protein during 
	that period. 
	 As with all materials of biological origin, this preparation should be 
	regarded as potentially hazardous to health. It should be used and 
	discarded according to your own laboratory's safety procedures. Such 
	safety procedures should include the wearing of protective gloves and 
	avoiding the generation of aerosols. Care should be exercised in 
	opening ampoules or vials, to avoid cuts. 
	3. UNITAGE 
	00/416 is assigned a value of 1.84% 480-A, 525-C, on the basis of a 
	WHO collaborative study. 
	4. CONTENTS 
	Country of origin of biological material: USA. 
	Each vial contains approximately 0.5ml of poliovirus type 1 (Sabin) grown 
	in serum free medium. Two poliovirus stocks containing 100% 480-A, 
	525-C, and 100% 480-G, 525-T were produced by PCR site directed 
	mutagenisis from cloned DNA. This DNA was reverse transcribed in vitro 
	and transfected into HEp2c cells. Before preparing the bulk, the stocks 
	were mixed in different proportions and tested by MAPREC to determine 
	the appropriate volumes of stock in the final bulk suspension that was 
	filled as 00/416. 
	5. STORAGE 
	The material should arrive frozen. 
	Unopened ampoules should be stored at –70°C or below. 
	6. DIRECTIONS FOR OPENING 
	Vials have a „flip-up‟ circular cap. Either on the cap or the collar of the 
	vial, there is an indication of the point at which to lever off the cap. This 
	exposes an area of the stopper through which reconstitution and 
	withdrawal of the preparation can be made using a hypodermic needle 
	and syringe. If use of a pipette is preferred, then fully remove the metal 
	collar using, for example, forceps, taking care to avoid cuts by wearing 
	appropriate gloves. Remove the stopper for access. Care should be 
	taken to prevent loss of the contents. 
	7. USE OF MATERIAL 
	A Standard Operating Procedure for the MAPREC assay is available 
	from; Chief, Biologicals, World Health Organization. This procedure 
	requires that an aliquot of 00/416 is tested in each MAPREC assay and 
	used to validate the test. 
	8. STABILITY 
	Reference materials are held at NIBSC within assured, temperaturecontrolled 
	storage facilities. Reference Materials should be stored on 
	receipt as indicated on the label. 
	NIBSC follows the policy of WHO with respect to its reference materials. 
	9. REFERENCES 
	a) WHO (2002) WHO Technical Report Series, 904, 31-91. 
	b) European Pharmacopoeia, 6th Edition (2009) Vaccines for human use, 
	Poliomyelitis vaccine oral 04/2008:0215. 
	c) WHO/BS/09.2103. WHO Technical Report Series. 
	10. ACKNOWLEDGEMENTS 
	 We would like ackowledge the help of the participants of the WHO 
	collaborative study to evaluate the Poliovirus type 1 MAPREC assay.  
	  声明:此对照品、标准品由【中检计量】提供网站查询购买服务 
	  注:点击cas,或者搜索:名称、编号、cas均可显示价格 | 
| 上一篇:脊髓灰质炎病毒1型(Sabin)的MAPREC分析100%480-A,525-C DNA(1st国际参考制 | 下一篇:没有了 | 
|---|
热销产品 新品上架
产品推荐 相关产品
- ·RMC001a PVC中6项邻苯二甲酸酯成分分析标准物质
- ·NIBSC92/788 白介素11(人类,rDNA衍生)WHO参考试剂
- ·RMG003 PVC中3项磷酸酯阻燃剂成分分析标准物质
- ·VIP(BS)IQC-216 丙型肝炎病毒核糖核酸(HCV RNA)血清(液体)室内质控品
- ·GBW(E)100582 水中咖啡因溶液标准物质
- ·GBW(E)090857-BW-079 丙型肝炎病毒抗体(抗-HCV)血清标准物质
- ·VIP(BS)IQC-104 叶酸代谢能力(MTHFR)基因分型全血质控品
- ·GBW07919 农用地土壤成分标准物质
- ·GBW02134 磷青铜成分分析标准物质
- ·GBW(E)090417 前列腺特异性抗原系列(液体)标准物质
- ·VIP(g)317574 Gymnoascus stercorarius
- ·D305200 rac Diacetolol标准品
- ·T114505 特非那定杂质A标准品
- ·USP-1325005 氢溴酸羟苯丙胺标准品(Hydroxyamphetamine Hydrobromide)
- ·P756005 L-Proline-N-Fmoc标准品
- ·BTLA-0834 氨氯地平杂质10标准品
- ·DC15425000 1,4-萘醌标准品
- ·B691495 5(叔丁基二甲硅烷基)氧基-2-巯基苯并咪唑标准品
- ·LD2510 Deferasirox Acyl beta-D-Glucuronide
- ·F229002 非布索坦-D9标准品(Febuxostat-d9)

